News|Articles|July 23, 2026

What Does It Take to Deliver CAR T-Cell Therapy in the Community?

Author(s)Ryu Kariyawasam-Chavez, Content Associate, Cassandra Perkey, PharmD, BCOP

Cassandra Perkey, PharmD, BCOP, explains the operational, staffing, infrastructure, safety, and pharmacist-led requirements for successfully delivering CAR T-cell therapy in a community oncology setting.

As chimeric antigen receptor (CAR) T-cell therapy expands beyond large academic medical centers, community oncology practices are increasingly evaluating whether they have the personnel, infrastructure, and operational capabilities required to deliver treatment safely in the outpatient setting.